Recurrent Liver Cancer: Reconceptualization and Reevaluation

Launched by NANJING MEDICAL UNIVERSITY · May 24, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at whether a specific protein in the blood can help doctors detect if liver cancer is coming back after treatment. The researchers will study two groups of patients: those who have recurrent liver cancer and those who have primary liver cancer (which means it started in the liver). By comparing the protein levels in these two groups, they hope to find out if higher levels of this protein can be a reliable way to monitor for cancer recurrence.

To participate in this study, you need to be diagnosed with liver cancer, either primary or recurrent, and be willing to provide blood samples and attend regular check-ups. The study is open to individuals aged 65 to 93, and both men and women can join. However, pregnant women, those who have had organ transplants, or patients with other cancers will not be eligible. If you decide to participate, you’ll help researchers gather important information that could improve how liver cancer is monitored in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with primary hepatocellular carcinoma or diagnosed with non-HCC
• • The patient or the patient's legal representative must be able to read, understand, and sign the informed consent form
• • Agree to provide blood samples and have good clinical compliance
• • Complete clinical basic information, including: the patient's unique traceability number (ID card number/outpatient number/health insurance card number), age, gender, imaging and/or pathological diagnosis results (for patients with primary liver disease), imaging examination confirmed heteromorphic liver cancer (for non-HCC patients)
• Exclusion Criteria:
• • Pregnant women
• • Those who have received organ transplantation
• • Non-HCC patients diagnosed with other tumors
• • Patients with primary hepatocellular carcinoma complicated by other tumors
• • Those judged by the researcher as not meeting the inclusion criteria